[{"Assets_0_Q3_USD":190500000.0,"CommonStockSharesOutstanding_0_Q3_shares":35967000.0,"EarningsPerShareBasic_1_Q3_USD":-0.19,"EarningsPerShareBasic_3_Q3_USD":-0.42,"EarningsPerShareDiluted_1_Q3_USD":-0.19,"EarningsPerShareDiluted_3_Q3_USD":-0.42,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1736000.0,"NetIncomeLoss_1_Q3_USD":-6621000.0,"NetIncomeLoss_3_Q3_USD":-14730000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":43908000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":127202000.0,"StockholdersEquity_0_Q3_USD":163407000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":35541000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":35075000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":35541000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":35075000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20181107"}]